Estrogenic Substance



Indications and Reactions:

Role Indications Reactions
Primary
Menopause 100.0%
Pharmaceutical Product Complaint 33.3%
Product Quality Issue 33.3%
Uterine Cancer 33.3%
Secondary
Hormone Replacement Therapy 57.9%
Menopause 13.2%
Product Used For Unknown Indication 8.5%
Drug Use For Unknown Indication 2.1%
Hot Flush 2.1%
Bone Disorder 1.8%
Ill-defined Disorder 1.8%
Menopausal Symptoms 1.8%
Oestrogen Replacement Therapy 1.5%
Hypertension 1.2%
Rheumatoid Arthritis 1.2%
Back Pain 0.9%
Cardiovascular Event Prophylaxis 0.9%
Infertility 0.9%
Migraine 0.9%
Neuropathy Peripheral 0.9%
Vulvovaginal Dryness 0.9%
Acne 0.6%
Multiple Sclerosis 0.6%
Transdermal Contraception 0.6%
Breast Cancer 49.1%
Breast Cancer Female 9.3%
Breast Cancer Metastatic 9.3%
Urticaria 4.6%
Thrombosis 3.7%
Vision Blurred 3.7%
Arrhythmia 1.9%
Herpes Zoster 1.9%
Metastases To Lymph Nodes 1.9%
Oedema Peripheral 1.9%
Ovarian Cancer 1.9%
Pulmonary Embolism 1.9%
Synovial Cyst 1.9%
Unresponsive To Stimuli 1.9%
Alopecia 0.9%
Breast Cancer Recurrent 0.9%
Breast Operation 0.9%
Completed Suicide 0.9%
Deep Vein Thrombosis 0.9%
Drug Interaction 0.9%
Concomitant
Product Used For Unknown Indication 26.0%
Drug Use For Unknown Indication 24.0%
Rheumatoid Arthritis 11.3%
Hormone Replacement Therapy 4.9%
Hypertension 4.1%
Depression 3.3%
Pain 3.1%
Crohn's Disease 3.0%
Blood Cholesterol Increased 2.4%
Anxiety 1.9%
Tonsil Cancer 1.8%
Insomnia 1.8%
Chronic Obstructive Pulmonary Disease 1.6%
Psoriasis 1.6%
Gastrooesophageal Reflux Disease 1.6%
Osteoporosis 1.6%
Vitamin Supplementation 1.6%
Migraine 1.5%
Psoriatic Arthropathy 1.5%
Multiple Sclerosis 1.3%
Drug Ineffective 9.6%
Weight Increased 9.6%
Vision Blurred 8.1%
Progressive Multifocal Leukoencephalopathy 7.4%
Urticaria 6.7%
Vomiting 5.2%
Fatigue 4.4%
Injection Site Pain 4.4%
Malaise 4.4%
Nausea 4.4%
Somnolence 4.4%
Weight Bearing Difficulty 4.4%
Weight Decreased 4.4%
Dizziness 3.7%
Pain In Extremity 3.7%
Arthritis 3.0%
Diarrhoea 3.0%
Flushing 3.0%
Hot Flush 3.0%
Injury 3.0%